|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
* From the Department of Medicine and the Center for Clinical Health Policy Research (Dr. McCrory), Duke University Medical Center, Department of Veterans Affairs Medical Center, Durham, NC; and American College of Chest Physicians (Dr. Lewis), Northbrook, IL.
Correspondence to: Douglas McCrory, MD, MHS, Duke Center for Clinical Health Policy Research 2200 W. Main St, Suite 220, Durham, NC 27705; e-mail: douglas.mccrory{at}duke.edu
The American College of Chest Physicians assembled a multidisciplinary, geographically diverse panel of experts in the treatment of pulmonary hypertension to develop clinically relevant practice guidelines for the diagnosis and treatment of pulmonary hypertension in its many variations. That group of experts produced recommendations covering five topic areas, each related to a distinct set of patient-management decisions. This article describes the approach used to develop the guidelines, including identifying, evaluating, and synthesizing the evidence, assessing the strength of evidence pertinent to individual guidelines, and grading guideline recommendations.
Key Words: clinical practice guidelines evidence-based medicine pulmonary hypertension
This article has been cited by other articles:
![]() |
S. D. Nathan Therapeutic Intervention: Assessing the Role of the International Consensus Guidelines Chest, November 1, 2005; 128(5_suppl_1): 533S - 539S. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E Baker and R. H. Hockman Inhaled Iloprost in Pulmonary Arterial Hypertension Ann. Pharmacother., July 1, 2005; 39(7): 1265 - 1274. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Claxton, J. T. Cohen, and P. J. Neumann When Is Evidence Sufficient? Health Aff., January 1, 2005; 24(1): 93 - 101. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |